First Manhattan CO Arrowhead Pharmaceuticals, Inc. Transaction History

First Manhattan CO

$29.6 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $7.54 Million - $11 Million	-355,433 Reduced 32.34%	743,721 $22.8 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $1.85 Million - $3.04 Million	73,500 Added 7.17%	1,099,154 $39.2 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $2.24 Million - $3.24 Million	-79,933 Reduced 7.23%	1,025,654 $41.6 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $31,852 - $51,933	-1,075 Reduced 0.1%	1,105,587 $36.5 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $594,706 - $1.08 Million	-21,400 Reduced 1.9%	1,106,662 $39 Million

Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $133,665 - $189,855	-2,301 Reduced 0.2%	1,128,062 $74.8 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $186,816 - $271,872	-3,200 Reduced 0.28%	1,130,363 $70.6 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $19,701 - $28,631	317 Added 0.03%	1,133,563 $93.9 Million
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $7.19 Million - $10.6 Million	-117,123 Reduced 9.37%	1,133,246 $75.1 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $14.4 Million - $28 Million	-328,104 Reduced 20.79%	1,250,369 $95.9 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $980,806 - $1.62 Million	-37,550 Reduced 2.32%	1,578,473 $68.2 Million
Q1 2020 May 06, 2020	SELL	$20.56 - $63.12 $9.29 Million - $28.5 Million	-451,997 Reduced 21.86%	1,616,023 $46.5 Million
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $26.9 Million - $69.7 Million	-954,305 Reduced 31.58%	2,068,020 $131 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $1.51 Million - $2 Million	-57,500 Reduced 1.87%	3,022,325 $85.2 Million
Q2 2019 Aug 16, 2019	SELL	$17.43 - $28.82 $32.1 Million - $53.1 Million	-1,843,700 Reduced 37.45%	3,079,825 $81.6 Million
Q1 2019 Apr 12, 2019	SELL	$12.05 - $20.18 $1.25 Million - $2.09 Million	-103,600 Reduced 2.06%	4,923,525 $90.3 Million
Q4 2018 Jan 30, 2019	SELL	$10.74 - $19.7 $287,832 - $527,960	-26,800 Reduced 0.53%	5,027,125 $62.4 Million
Q3 2018 Oct 15, 2018	BUY	$14.0 - $20.3 $7.33 Million - $10.6 Million	523,675 Added 11.56%	5,053,925 $96.9 Million
Q1 2018 Apr 20, 2018	BUY	$3.72 - $7.64 $5.02 Million - $10.3 Million	1,348,900 Added 42.4%	4,530,250 $32.7 Million
Q4 2017 Jan 22, 2018	BUY	$3.14 - $4.5 $9.99 Million - $14.3 Million	3,181,350	3,181,350 $11.7 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account